MA30166B1 - Imidazoles substitues et leur utilisation comme pesticides. - Google Patents

Imidazoles substitues et leur utilisation comme pesticides.

Info

Publication number
MA30166B1
MA30166B1 MA31128A MA31128A MA30166B1 MA 30166 B1 MA30166 B1 MA 30166B1 MA 31128 A MA31128 A MA 31128A MA 31128 A MA31128 A MA 31128A MA 30166 B1 MA30166 B1 MA 30166B1
Authority
MA
Morocco
Prior art keywords
pesticides
substituted imidazoles
substituted
parasiticides
solvates
Prior art date
Application number
MA31128A
Other languages
English (en)
Inventor
Nathan Anthony Logan Chubb
Mark Roger Cox
Jerome Sebastien Dauvergne
Richard Andrew Ewin
Christelle Lauret
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MA30166B1 publication Critical patent/MA30166B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Imidazoles substitués et leur utilisation comme pesticides La présente invention concerne un ensemble de dérivés d'imidazole à substituant 2-benzyle alpha-substitués et leurs sels et produits de solvatation pharmaceutiquement acceptables, des compositions comprenant ces composés, des procédés pour leur synthèse, ainsi que leur utilisation comme parasiticides.
MA31128A 2006-01-19 2008-07-18 Imidazoles substitues et leur utilisation comme pesticides. MA30166B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76076506P 2006-01-19 2006-01-19

Publications (1)

Publication Number Publication Date
MA30166B1 true MA30166B1 (fr) 2009-01-02

Family

ID=38038547

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31128A MA30166B1 (fr) 2006-01-19 2008-07-18 Imidazoles substitues et leur utilisation comme pesticides.

Country Status (32)

Country Link
US (4) US7592362B2 (fr)
EP (2) EP2423199A1 (fr)
JP (1) JP4463317B2 (fr)
KR (1) KR101044494B1 (fr)
CN (1) CN101370786B (fr)
AR (1) AR059055A1 (fr)
AT (1) ATE505461T1 (fr)
AU (1) AU2007206698B2 (fr)
BR (1) BRPI0707185B8 (fr)
CA (1) CA2632771C (fr)
CY (1) CY1111473T1 (fr)
DE (1) DE602007013869D1 (fr)
DK (1) DK1981853T3 (fr)
EA (1) EA015738B1 (fr)
ES (1) ES2362935T3 (fr)
HK (1) HK1127919A1 (fr)
IL (1) IL192063A0 (fr)
MA (1) MA30166B1 (fr)
ME (2) ME00044B (fr)
MY (1) MY145812A (fr)
NO (1) NO341141B1 (fr)
NZ (1) NZ569209A (fr)
PL (1) PL1981853T3 (fr)
PT (1) PT1981853E (fr)
RS (1) RS53512B1 (fr)
SI (1) SI1981853T1 (fr)
TN (1) TNSN08306A1 (fr)
TW (1) TWI337998B (fr)
UA (1) UA93696C2 (fr)
UY (1) UY30096A1 (fr)
WO (1) WO2007083207A1 (fr)
ZA (1) ZA200805565B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100623106B1 (ko) 1998-11-02 2006-09-13 다우 글로벌 테크놀로지스 인크. 전단시닝 에틸렌／α―올레핀 인터폴리머 및 그의 제조 방법
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
US20100041712A1 (en) * 2008-08-18 2010-02-18 Pfizer Inc. Substituted imidazole combinations
CN102307852B (zh) 2008-12-24 2013-12-18 第一三共株式会社 环状胺化合物
CN102307847A (zh) 2008-12-24 2012-01-04 第一三共株式会社 茚满基化合物
US20120041042A1 (en) 2009-02-23 2012-02-16 Wyeth Llc Scent Ectoparasiticidal Formulation
JP5714578B2 (ja) * 2009-07-16 2015-05-07 ゾルファイ フルーオル ゲゼルシャフト ミット ベシュレンクテル ハフツングＳｏｌｖａｙ Ｆｌｕｏｒ ＧｍｂＨ フルオロアルキル（フルオロ）アルキルカーボネートおよびカルバメートの調製方法
EP2521545B1 (fr) * 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Promédicaments de composés hétéroaromatiques
KR20120120376A (ko) 2010-01-29 2012-11-01 화이자 인코포레이티드 국소 항기생충 제제
CN102127066B (zh) * 2010-12-10 2013-08-14 邵阳学院 4-(7-甲氧基-2,2-二甲基-2,3-二氢苯并呋喃-5-基)-2-(3,4-二甲苯氨基)噻唑手性晶体
WO2012139010A1 (fr) * 2011-04-08 2012-10-11 University Of Kansas Inhibiteurs de grp94
US9295623B2 (en) * 2011-10-03 2016-03-29 Eq Ag Solutions Methods of preventing the transmission of communicable diseases in livestock
AU2012340351B2 (en) 2011-11-17 2017-06-15 Boehringer Ingelheim Animal Health USA Inc. Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
EP3184512B1 (fr) 2012-01-13 2020-12-23 The General Hospital Corporation Composés anesthésiants et procédés d'utilisation associés
CN102987824A (zh) * 2012-11-29 2013-03-27 张敏 一种防螨虫被
CN104844459B (zh) * 2014-02-18 2016-08-24 扬州三友合成化工有限公司 一种氯甲基异丙基碳酸酯的制备方法
CN108349953B (zh) * 2015-11-18 2022-06-17 孟山都技术公司 杀虫组合物和方法
ES2909709T3 (es) * 2016-05-12 2022-05-10 Heptares Therapeutics Ltd Inhibidores del receptor 2 activado por proteasa
WO2019089631A1 (fr) * 2017-10-30 2019-05-09 University Of North Texas Health Science Center At Fort Worth Agents de dissuasion pour arthropodes et organismes marins
CN115073298A (zh) * 2022-05-31 2022-09-20 湖南华腾制药有限公司 连续流微反应器合成2-甲基-3-三氟甲基苯胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678775A (en) * 1984-05-01 1987-07-07 Nathanson James A Method of controlling pests
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
SU1655293A3 (ru) * 1987-04-21 1991-06-07 Басф Аг (Фирма) Средство дл борьбы с насекомыми
RU2026294C1 (ru) * 1990-06-29 1995-01-09 Сумитомо Кемикал Компани, Лимитед Производные 1-пиридилимидазола и инсектицидная композиция
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
FR2681322B1 (fr) 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
JP3311858B2 (ja) 1994-03-08 2002-08-05 四国化成工業株式会社 銅及び銅合金の表面処理剤
IL136388A0 (en) 1997-12-04 2001-06-14 Allergan Sales Inc Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
TWI283669B (en) 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
AU6263100A (en) 1999-06-25 2001-01-31 Bayer Aktiengesellschaft Method for copolymerizing polar and non-polar monomers
AU2001264872A1 (en) 2000-06-05 2001-12-17 Ortho-Mcneil Pharmaceutical, Inc. Method for synthesis of substituted azole libraries
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
DE10304374A1 (de) 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP1636183A1 (fr) 2003-05-16 2006-03-22 Ambit Biosciences Corporation Composes pyrroliques et leurs utilisations
US7812163B2 (en) * 2003-07-16 2010-10-12 Hatchtech Pty Ltd. Methods and compositions for controlling ectoparasites
AU2003903686A0 (en) 2003-07-16 2003-07-31 Hatchtech Pty Ltd Methods and compositions for controlling ectoparasites
JP4795242B2 (ja) * 2003-09-25 2011-10-19 ドムペ・ファ．ル．マ・ソチエタ・ペル・アツィオーニ アミジン及びその誘導体並びにそれを含有する医薬組成物
EP1584335A3 (fr) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Combinaison de substances actives comprenant un composé carbinol et un opioïde
KR20080009144A (ko) * 2005-05-03 2008-01-24 바이엘 크롭사이언스 아게 살충성을 가지는 치환된 아미노알킬 헤테로사이클릭 및헤테로아릴 유도체
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
AU2007209381A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of substituted 2-imidazole of imidazoline derivatives

Also Published As

Publication number Publication date
EP1981853B1 (fr) 2011-04-13
CY1111473T1 (el) 2015-08-05
US7547718B2 (en) 2009-06-16
RS53512B1 (en) 2015-02-27
CA2632771C (fr) 2011-03-22
MEP4208A (en) 2010-06-10
CA2632771A1 (fr) 2007-07-26
EA015738B1 (ru) 2011-10-31
SI1981853T1 (sl) 2011-08-31
EP1981853A1 (fr) 2008-10-22
TW200738644A (en) 2007-10-16
CN101370786A (zh) 2009-02-18
UY30096A1 (es) 2007-08-31
US7592362B2 (en) 2009-09-22
BRPI0707185A2 (pt) 2011-04-26
EA200870079A1 (ru) 2009-02-27
RS20080304A (en) 2009-05-06
DK1981853T3 (da) 2011-06-20
AU2007206698A1 (en) 2007-07-26
MY145812A (en) 2012-04-30
KR101044494B1 (ko) 2011-06-27
AR059055A1 (es) 2008-03-12
BRPI0707185B1 (pt) 2020-03-17
WO2007083207A1 (fr) 2007-07-26
AU2007206698B2 (en) 2011-11-03
TWI337998B (en) 2011-03-01
JP2009528979A (ja) 2009-08-13
US20080119536A1 (en) 2008-05-22
US20070167506A1 (en) 2007-07-19
PT1981853E (pt) 2011-06-27
EP2423199A1 (fr) 2012-02-29
PL1981853T3 (pl) 2011-08-31
US7825149B2 (en) 2010-11-02
NO20083404L (no) 2008-08-04
TNSN08306A1 (fr) 2009-12-29
KR20080085046A (ko) 2008-09-22
ZA200805565B (en) 2009-12-30
ES2362935T3 (es) 2011-07-15
CN101370786B (zh) 2012-01-11
DE602007013869D1 (de) 2011-05-26
US20090312326A1 (en) 2009-12-17
NZ569209A (en) 2010-09-30
HK1127919A1 (en) 2009-10-09
ME00044B (me) 2010-06-10
IL192063A0 (en) 2008-12-29
NO341141B1 (no) 2017-08-28
ATE505461T1 (de) 2011-04-15
US20080125473A1 (en) 2008-05-29
BRPI0707185B8 (pt) 2021-05-25
JP4463317B2 (ja) 2010-05-19
UA93696C2 (ru) 2011-03-10
US7544706B2 (en) 2009-06-09

Similar Documents

Publication Publication Date Title
MA30166B1 (fr) Imidazoles substitues et leur utilisation comme pesticides.
MA29549B1 (fr) Arylpyrazoles substitues destines a etre utilises contre des parasites
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
MA54327B1 (fr) Inhibiteurs de kras g12c
MA30988B1 (fr) Composes destines a inhiber la progression mitotique
MA30883B1 (fr) Nouveaux derives de 1,1 - dioxyde de 1.4 - benzothiepine substitues par des radicaux benzyle, leur procede de preparation, les produits pharmaceutiques comprenant ces composes et leur utilisation
MA30781B1 (fr) Inhibiteur de kinase
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA30483B1 (fr) Utilisation de biphenylamides d'acide arylcarboxylique pour le traitement de semences.
MA29550B1 (fr) Derives de n- (pyridine-2-yl) - sulfonamide
MA31655B1 (fr) Pyrimidines cyclopenta [d] hydroxylés et méthoxylés utilisés en tant qu'inhibiteurs de la protéine kinase akt.
MA31580B1 (fr) Derives de bicyclolactames substitués
MA31593B1 (fr) Derives de 2-aza-bicyclo[3.3.0]octane
TNSN08139A1 (fr) Composes therapeutiques
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
MA30686B1 (fr) Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase.
MA30952B1 (fr) Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la proteine kinase akt
TN2010000052A1 (fr) Derives de pyrazole et leur utilisation comme inhibiteurs de raf
MA31419B1 (fr) Derives de pyridine
MA28269A1 (fr) Arylpyrazoles substitués servant d'agents parasiticides
MA29685B1 (fr) Composes spiroheterocycliques et leurs utilisations en tant qu'agents therapeutiques
MA31087B1 (fr) Derives d'amide et d'ester d'indazolyle pour traiter des troubles medies par le recepteur de glucocorticoïde.
MA30351B1 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
MA31763B1 (fr) Inhibiteurs de kinase de type polo
MA30959B1 (fr) Composes de pyrazole et de triazole substitues comme inhibiteurs de ksp